MARGARET G MCGLYNN Insider Trading $FOLD AMICUS THERAPEUTICS, INC.
Get free email notifications about insider trading for MARGARET G MCGLYNN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARGARET G MCGLYNN. MARGARET G MCGLYNN is Director in AIR PRODUCTS & CHEMICALS INC /DE/ ($APD) and Pres.U.S.Human Health in MERCK SHARP & DOHME CORP. ($MRK) and President, GV & ID in MERCK SHARP & DOHME CORP. ($MRK) and President, Merck Vaccines in MERCK SHARP & DOHME CORP. ($MRK) and President, MV & ID in MERCK SHARP & DOHME CORP. ($MRK) and Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in NOVAVAX INC ($NVAX) and Director in AMICUS THERAPEUTICS INC ($FOLD).
MARGARET G MCGLYNN in AMICUS THERAPEUTICS, INC.
Trading Symbol: FOLDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARGARET G MCGLYNN: Director
Holdings: 37,919 shares
Current Value: $228,272
Latest Transaction: May 05 2021
$FOLD Market Capitalization: $869.61M
$FOLD Previous Close: $6.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARGARET G MCGLYNN in AMICUS THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APD, FOLD, MRK, NVAX, VRTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 7.51 | 10,000 | 75,100 | 0 | |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 10.27 | 10,000 | 102,704 | 27,919 | 37.9 K to 27.9 K (-26.37 %) |
May 05 2021 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 7.51 | 10,000 | 75,100 | 37,919 | 27.9 K to 37.9 K (+35.82 %) |
Jun 08 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 12.81 | 18,574 | 237,933 | 18,574 | |
Jun 08 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 5,855 | 0 | 27,919 | 22.1 K to 27.9 K (+26.54 %) |
Apr 20 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 2.81 | 10,000 | 28,100 | 0 | |
Apr 20 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 11.00 | 10,000 | 110,000 | 22,064 | 32.1 K to 22.1 K (-31.19 %) |
Apr 20 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 2.81 | 10,000 | 28,100 | 32,064 | 22.1 K to 32.1 K (+45.32 %) |
Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 3.32 | 20,000 | 66,400 | 0 | |
Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 10.00 | 20,000 | 200,000 | 22,064 | 42.1 K to 22.1 K (-47.55 %) |
Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 3.32 | 20,000 | 66,400 | 42,064 | 22.1 K to 42.1 K (+90.65 %) |
Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 12.00 | 19,473 | 233,676 | 19,473 | |
Jul 01 2019 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 6,250 | 0 | 22,064 | 15.8 K to 22.1 K (+39.52 %) |
Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 16.23 | 8,912 | 144,642 | 8,912 | |
Jun 11 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 3,081 | 0 | 8,895 | 5.8 K to 8.9 K (+52.99 %) |
May 18 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 3.32 | 10,000 | 33,200 | 20,000 | |
May 18 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Sell | S | 16.00 | 10,000 | 160,000 | 15,814 | 25.8 K to 15.8 K (-38.74 %) |
May 18 2018 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | M | 3.32 | 10,000 | 33,200 | 25,814 | 15.8 K to 25.8 K (+63.24 %) |
Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 8.60 | 16,236 | 139,630 | 16,236 | |
Jun 15 2017 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Grant | A | 0.00 | 5,814 | 0 | 5,814 | 0 to 5.8 K |
Jun 13 2016 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 6.71 | 20,000 | 134,200 | 20,000 | |
Nov 10 2015 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Buy | P | 10.27 | 10,000 | 102,657 | 10,000 | 0 to 10 K |
Jun 12 2015 | FOLD | AMICUS THERAPEUTIC ... | MCGLYNN MARGARET G | Director | Option Exercise | A | 13.09 | 20,000 | 261,800 | 20,000 |
Page: 1